Tag Archives: CBD

December, 2018

November, 2018

September, 2018

  • 27 September

    DEA Reschedules GW Pharma’s Epidiolex (cannabidiol) Oral Solution to Schedule V

    LONDON and CARLSBAD, Calif., Sept. 27, 2018 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH, “GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, along with its U.S. subsidiary Greenwich Biosciences, announced today that EPIDIOLEX® (cannabidiol) oral …

June, 2018

April, 2018

December, 2017

September, 2017

  • 29 September

    Zynerba’s Cannabis-Based Drug Demonstrates Positive Results in Study in Fragile X Syndrome

    DEVON, Pa., Sept. 28, 2017 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to developing and commercializing innovative pharmaceutically-produced transdermal cannabinoid treatments, today announced positive top line results from an open label exploratory Phase 2 FAB-C (Treatment of Fragile X Syndrome Anxiety and Behavioral Challenges with CBD) clinical trial evaluating ZYN002 cannabidiol …

June, 2017

May, 2017